Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options 
CLS Holdings USA, Inc. Announces Joint Venture with Ranson Shepherd to Manufacture Pre-Rolls
LAS VEGAS, NV / ACCESSWIRE / September 28, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'',...
NeonMind Advances Strategy for Specialty Clinic Launch
Company expects to launch first specialty clinic locations by early 2022NeonMind-branded specialty mental health clinics to bring innovative interventional psychiatry...
Relief Reports that its U.S. Collaboration Partner has Announced Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMITM (RLF-100TM/aviptadil)
GENEVA, SWITZERLAND / ACCESSWIRE / September 28, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) ("Relief"), a biopharmaceutical company seeking to...
AgriCann Solutions Drops Acquisition of Sticky Leaf & Provides Updates
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - AgriCann Solutions Corp. (the "Company" or "AgriCann"), a full-service premium Cannabis...
Vensana Capital Raises $325 Million and Expands Team to Back Transformative Medical Technology Innovations
MINNEAPOLIS & WASHINGTON--(BUSINESS WIRE)--Vensana Capital today announced the closing of its second fund, Vensana Capital II, with $325 million in...
StageZero Life Sciences Announces Commencement of Trading on the OTCQB
TORONTO, ON / ACCESSWIRE / September 27, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (the "Company" or "StageZero"), a healthcare...
Aytu BioPharma Reports Fourth Quarter and Full-Year Fiscal 2021 Financial Results
Quarterly net revenue increased 74% sequentially to $23.5M; 138% year-over-year to $65.6MEnded quarter with approximately $50M in cash, cash equivalents...
CuePath Signs First Three USA Home Care Agency Partners; Expands Canadian Sales; Appoints John Hunt, VP International Sales
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - CuePath Innovation, a provider of medication adherence solutions for the home...
Jaguar Health Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Cancer Therapy-related Diarrhea on September 29, 2021
Leading oncologists discuss importance of supportive care for cancer patients to address debilitating diarrhea resulting from cancer therapyVirtual event 1:00...
Altamira Therapeutics Provides Update on Bentrio Program
Building Bentrio™ brand and expanding in European markets510(k) premarket notification for allergy indication submitted to the U.S. Food and Drug...
9 Meters Biopharma, Inc. Announces Partnership with Non-Profit Gluten-Free Food Pantry Organization Mend Hunger
RALEIGH, NC / ACCESSWIRE / September 27, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR) (the "Company"), a clinical-stage company pioneering...
Adverum to Present Data from ADVM-022 Clinical Trials at Upcoming Medical Conferences
REDWOOD CITY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting...
Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
Proven commercial leader with broad global experience in building and running commercial organizations and successfully launching products for people with...
PacBio Partners with The European Reference Genome Atlas Initiative
Partnership to improve biodiversity research, accelerate conservation with actionable and accurate genomic dataMENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE)...
Cannabix Technologies Ramps Up Beta Testing with THC Breathalyzer and Ships Additional Devices
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company’s Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage
Study expected to be completed in the first half of 2022, with the goal to commence the Phase 3 safety...
PDS Biotechnology to Present at the Benzinga Healthcare Conference
FLORHAM PARK, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotech” or the “Company”, Nasdaq: PDSB), a...
Sarepta Therapeutics to Initiate Part B of MOMENTUM Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping Following Positive Interactions with FDA
- Company Anticipates Part B of MOMENTUM to Serve as Pivotal Study for SRP-5051 and to Seek Accelerated Approval if...
ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis
Approved for use in Japan in patients with microscopic polyangiitis and granulomatosis with polyangiitisSAN CARLOS, Calif., Sept. 27, 2021 (GLOBE...
Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of its Population Health Offering
NEVE ILAN, Israel, Sept. 27, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical...